OCREVUS ZUNOVO

ocrelizumab and hyaluronidase · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OCREVUS ZUNOVO, covering 2024-09-13 to 2025-08-18. Get the full timeline:

Most recent: FDA Approved: OCREVUS ZUNOVO — Supplemental Application (Genentech, Inc.)